Multiple Inflammatory Biomarker Detection in a Prospective Cohort Study: A Cross-Validation between Well-Established Single-Biomarker Techniques and an Electrochemiluminescense-Based Multi-Array Platform

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  van Bussel, Bas C T ^a,b,c   Ferreira, Isabel ^a,d,e   van de Waarenburg, Marjo P H ^a,c   van Greevenbroek, Marleen M J ^a,e   van der Kallen, Carla J H ^a,e   Henry, Ronald M A ^a,c,e   Feskens, Edith J M ^c,f   Stehouwer, Coen D A ^a,b,c,e   Schalkwijk, Casper G ^a,c,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; SERUM AMYLOID A; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

4 PLEX MULTI ARRAY ELECTROCHEMOLUMINESCENCE; ANALYTICAL EQUIPMENT; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE METABOLISM; HUMAN; IMMUNOASSAY; IMMUNOTURBIDIMETRY; INFLAMMATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SMOKING; TURBIDIMETRY; VALIDATION PROCESS; AGED; BLOOD; BODY MASS; DNA MICROARRAY; ELECTROCHEMISTRY; FEMALE; GLUCOSE BLOOD LEVEL; LUMINESCENCE; MALE; METABOLISM; MIDDLE AGED; PHOTOMETRY; PROCEDURES; VALIDATION STUDY;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; ELECTROCHEMISTRY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LUMINESCENCE; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSPECTIVE STUDIES; SERUM AMYLOID A PROTEIN; SMOKING; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84874598596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058576     Document Type: Article

References (41)

1. Borissoff JI, Spronk HM, ten Cate H, (2011) The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364: 1746-1760.
2. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
3. Becker A, van Hinsbergh VW, Jager A, Kostense PJ, Dekker JM, et al. (2002) Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality? Eur J Clin Invest 32: 1-8.
4. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, et al. (2001) Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104: 1336-1342.
5. Kaplan RC, McGinn AP, Baird AE, Hendrix SL, Kooperberg C, et al. (2008) Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study. J Stroke Cerebrovasc Dis 17: 344-355.
6. Ridker PM, Hennekens CH, Buring JE, Rifai N, (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843.
7. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, et al. (2007) Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation 115: 2119-2127.
8. Vasan RS, (2006) Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113: 2335-2362.
9. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511.
10. Schnabel RB, Larson MG, Yamamoto JF, Kathiresan S, Rong J, et al. (2009) Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 104: 92-96.
11. Conen D, Ridker PM, Everett BM, Tedrow UB, Rose L, et al. (2010) A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J 31: 1730-1736.
12. Kim HC, Greenland P, Rossouw JE, Manson JE, Cochrane BB, et al. (2010) Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol 55: 2080-2091.
13. Daniels LB, Maisel AS, (2010) Multiple marker approach to risk stratification in patients with stable coronary artery disease: to have or have not. Eur Heart J 31: 2980-2983.
14. Wang TJ, (2010) Multiple biomarkers for predicting cardiovascular events: lessons learned. J Am Coll Cardiol 55: 2092-2095.
15. Gruson D, Bodovitz S, (2010) Rapid emergence of multimarker strategies in laboratory medicine. Biomarkers 15: 289-296.
16. Tedgui A, Mallat Z, (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581.
17. Thanabalasingham G, Shah N, Vaxillaire M, Hansen T, Tuomi T, et al. (2010) A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 54: 2801-2810.
18. Myers GL, Rifai N, Tracy RP, Roberts WL, Alexander RW, et al. (2004) CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 110: e545-549.
19. Marchese RD, Puchalski D, Miller P, Antonello J, Hammond O, et al. (2009) Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum. Clin Vaccine Immunol 16: 387-396.
20. Oh ES, Mielke MM, Rosenberg PB, Jain A, Fedarko NS, et al. (2010) Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-beta in plasma. J Alzheimers Dis 21: 769-773.
21. Prabhakar U, Eirikis E, Davis HM, (2002) Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods 260: 207-218.
22. Dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL, (2005) Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 66: 175-191.
23. de Koning L, Liptak C, Shkreta A, Bradwin G, Hu FB, et al. (2012) A multiplex immunoassay gives different results than singleplex immunoassays which may bias epidemiologic associations. Clin Biochem doi:10.1016/j.clinbiochem.2012.1004.1006.
24. Steffes M, Cleary P, Goldstein D, Little R, Wiedmeyer HM, et al. (2005) Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem 51: 753-758.
25. Cull CA, Manley SE, Stratton IM, Neil HA, Ross IS, et al. (1997) Approach to maintaining comparability of biochemical data during long-term clinical trials. Clin Chem 43: 1913-1918.
26. Maahs DM, Jalal D, McFann K, Rewers M, Snell-Bergeon JK, (2011) Systematic shifts in cystatin C between 2006 and 2010. Clin J Am Soc Nephrol 6: 1952-1955.
27. Selvin E, Coresh J, Zhu H, Folsom A, Steffes MW, (2010) Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study. J Diabetes 2: 118-124.
28. Kruijshoop M, Feskens EJ, Blaak EE, de Bruin TW, (2004) Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population. Clin Chim Acta 341: 33-40.
29. Du H, van der AD, van Bakel MM, van der Kallen CJ, Blaak EE, et al. (2008) Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population. Am J Clin Nutr 87: 655-661.
30. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, et al. (2009) Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest 39: 437-444.
31. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, et al. (2010) The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study. Eur J Clin Invest 41: 167-175.
32. Thewissen MM, Damoiseaux JG, Duijvestijn AM, van Greevenbroek MM, van der Kallen CJ, et al. (2010) Abdominal Fat Mass Is Associated With Adaptive Immune Activation: The CODAM Study. Obesity (Silver Spring) 19: 1690-1698.
33. van Greevenbroek MM, Jacobs M, van der Kallen CJ, Blaak EE, Jansen EH, et al. (2012) Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study). Int J Cardiol 154: 158-162.
34. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, et al. (2007) Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53: 766-772.
35. van Bussel BC, Schouten F, Henry RM, Schalkwijk CG, de Boer MR, et al. (2011) Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension 58: 588-595.
36. van Bussel BC, Henry RM, Schalkwijk CG, Dekker JM, Nijpels G, et al. (2012) Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study. J Hypertens 30: 744-752.
37. Linnet K, (1998) Performance of Deming regression analysis in case of misspecified analytical error ratio in method comparison studies. Clin Chem 44: 1024-1031.
38. Martin RF, (2000) General deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 46: 100-104.
39. Bland JM, Altman DG, (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
40. Twomey PJ, (2006) How to use difference plots in quantitative method comparison studies. Ann Clin Biochem 43: 124-129.
41. de Vet HC, Terwee CB, Knol DL, Bouter LM, (2006) When to use agreement versus reliability measures. J Clin Epidemiol 59: 1033-1039.